Toxicity of oral adjuvant chemotherapy in breast cancer.
作者信息
Murray J G, MacIntyre J, Leiberman D P, Leaper D J
出版信息
Br Med J. 1978 Feb 18;1(6110):408-9. doi: 10.1136/bmj.1.6110.408-a.
Abstract
摘要
相似文献
1
Toxicity of oral adjuvant chemotherapy in breast cancer.乳腺癌口服辅助化疗的毒性
Br Med J. 1978 Feb 18;1(6110):408-9. doi: 10.1136/bmj.1.6110.408-a.
2
Oral adjuvant therapy in breast carcinoma--a multicentre trial.乳腺癌的口服辅助治疗——一项多中心试验。
Cancer Treat Rev. 1979 Jun;6 Suppl:91-6. doi: 10.1016/s0305-7372(79)80020-1.
3
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy.乳房切除术后辅助化疗相关的精神疾病发病率和身体毒性。
Br Med J. 1980 Nov 1;281(6249):1179-80. doi: 10.1136/bmj.281.6249.1179.
4
Adjuvant chemotherapy for early breast cancer.早期乳腺癌的辅助化疗。
Br Med J (Clin Res Ed). 1983 Aug 6;287(6389):379-80. doi: 10.1136/bmj.287.6389.379.
5
Melphalan and methotrexate in advanced breast cancer.美法仑与甲氨蝶呤治疗晚期乳腺癌
Cancer Treat Rep. 1978 Dec;62(12):2111-2.
6
7
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.
J Clin Oncol. 1997 Jun;15(6):2312-21. doi: 10.1200/JCO.1997.15.6.2312.
8
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
Cancer Treat Rep. 1977 Nov;61(8):1603-5.
9
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较：西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
10
Anaphylaxis due to oral melphalan.口服美法仑引起的过敏反应。
Cancer Treat Rep. 1980 Apr-May;64(4-5):731-2.
引用本文的文献
1
Adjuvant chemotherapy of breast cancer: hope--reality--hazard?乳腺癌辅助化疗：希望——现实——风险？
Klin Wochenschr. 1984 Feb 15;62(4):149-61. doi: 10.1007/BF01731637.
2
Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate.关于吲哚美辛增强甲氨蝶呤抗癌作用机制的研究。
Br J Pharmacol. 1987 May;91(1):229-35. doi: 10.1111/j.1476-5381.1987.tb09003.x.
3
Review of general surgery 1978.普通外科学综述，1978年
Postgrad Med J. 1979;55(642):223-40. doi: 10.1136/pgmj.55.642.223.
本文引用的文献
1
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.用于治疗腋窝淋巴结阳性的可手术乳腺癌的CMF方案。关于无病生存期、复发部位和药物耐受性的最新分析。
Cancer. 1977 Jun;39(6 Suppl):2904-15. doi: 10.1002/1097-0142(197706)39:6<2904::aid-cncr2820390677>3.0.co;2-8.
2
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
Cancer. 1977 Jun;39(6 Suppl):2883-903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9.
Zotero 插件